← Leaderboards
Honoria M Guarino
National Development And Research Institutes, Inc.
$2,748,031
Attributed
$5,189,061
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,189,061 · 4
By mechanism
R01$3,602,994 · 1
R34$1,279,067 · 2
R03$307,000 · 1
Top collaborators
- Pedro Mateu-Gelabert5 shared
- Michelle C Acosta4 shared
- Camila Gelpi-Acosta3 shared
Most similar at National Development And Research Institutes, Inc.
Same institution · by research overlap
- Michelle C Acosta$1,739,580
- Pedro Mateu-Gelabert$5,944,655
- Camila Gelpi-Acosta$611,815
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsPreventRisk BehaviorsReportingEffectivenessHiv/HcvInnovationTrainingSocialDrug UsageHigh RiskHeroinYouthEpidemicBehavioralPublic Health RelevanceInjection Drug UseYoung AdultHepatitis C PrevalenceHepatitis CEvidence BaseFocus GroupsPreventive InterventionDisease Outbreaks
Grant awards (14)
Ending HIV and Taming HCV and Overdose Among Puerto Rican PWID in New York City: The Ganchero Intervention$133,329
R34 · FY2025 · DA
Ending HIV and Taming HCV and Overdose Among Puerto Rican PWID in New York City: The Ganchero Intervention$285,360
R34 · FY2024 · DA
Ending HIV and Taming HCV and Overdose Among Puerto Rican PWID in New York City: The Ganchero Intervention$165,213
R34 · FY2023 · DA
The Staying Safe Intervention: Preventing HCV among Young Opioid Injectors$693,559
R01 · FY2020 · DA
The Staying Safe Intervention: Preventing HCV among Young Opioid Injectors$661,249
R01 · FY2019 · DA
Preventing Injection: An mHealth intervention that leverages social networks to prevent progression to injection among young opioid users$73,414
R34 · FY2019 · DA
Preventing Injection: An mHealth intervention that leverages social networks to prevent progression to injection among young opioid users$7,751
R34 · FY2019 · DA
The Staying Safe Intervention: Preventing HCV among Young Opioid Injectors$739,640
R01 · FY2018 · DA
Preventing Injection: An mHealth intervention that leverages social networks to prevent progression to injection among young opioid users$345,375
R34 · FY2018 · DA
The Staying Safe Intervention: Preventing HCV among Young Opioid Injectors$746,948
R01 · FY2017 · DA
Preventing Injection: An mHealth intervention that leverages social networks to prevent progression to injection among young opioid users$268,625
R34 · FY2017 · DA
The Staying Safe Intervention: Preventing HCV among Young Opioid Injectors$761,598
R01 · FY2016 · DA
Opioid Use and HIV/HCV Risk among Immigrant Youth from the Former Soviet Union$153,500
R03 · FY2014 · DA · contact PI
Opioid Use and HIV/HCV Risk among Immigrant Youth from the Former Soviet Union$153,500
R03 · FY2013 · DA · contact PI